Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin
Karp, Daniel D., Pollak, Michael N., Cohen, Roger B., Eisenberg, Peter D., Haluska, Paul, Yin, Donghua, Lipton, Allan, Demers, Laurence, Leitzel, Kim, Hixon, Mary L., Terstappen, Leon W., Garland, LinVolume:
4
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e3181ba2f1d
Date:
November, 2009
File:
PDF, 338 KB
english, 2009